New Products

New products that boasted either a “healthier-for-you” or “let’s-get-well” factor proved the most successful in 2013, according to IRI’s 2013 New Product Pacesetters report.

PURCHASE, N.Y. — Mountain Dew, a brand from PepsiCo, on Thursday announced that for the first time, Mtn Dew Baja Blast — which is only available as a fountain beverage at Taco Bell — will make the leap to store shelves for a limited time beginning May 5.

SILVER SPRING, Md. — The Food and Drug Administration on Wednesday approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease, a rare disorder similar to lymphoma (cancer of the lymph nodes).

MCD causes an abnormal overgrowth of immune cells in lymph nodes and related tissues in the body. The disease usually affects adults who often suffer from fever, night sweats, weight loss and weakness or fatigue because their body’s immune system is weakened and cannot fight infections.

NEW YORK — Cefaly Technology announced Wednesday that the Cefaly medical device for the preventive treatment of migraine headaches is available for purchase and delivery in the United States for patients with a medical prescription at Cefaly.us.

The company that manufactures Cefaly expects to make the device available via select pharmacies and clinics in the months ahead. 

SOUTH DEERFIELD, Mass. — The Yankee Candle Co. announced the launch of Dream Garden, a limited-edition collection of garden fragrances. The line was inspired by the garden parties and consists of three fragrances: Garden Time, Blue Lavender and Sweet Pink.

Garden Time evokes the scent of fresh garden herbs; Blue Lavender mimics the scent of fresh lavender sprigs; and Sweet Pink contains a blend of sweet floral nectars.

WHIPPANY, N.J. — Bayer HealthCare on Tuesday announced that the Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for Bayer's investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis. Patients with NCFB suffer from frequent severe acute pulmonary bacterial exacerbations, which lead to further inflammation, airway and lung parenchyma damage.

HOUSTON — Last weekend marked the in-store retail debut of the Prettie Girls!, a line of multicultural dolls, at H-E-B stores. The dolls were well-received by customers and sold out completely after just a few hours, the grocer said.

HYDERABAD, India — Dr. Reddy's Labs on Wednesday announced the launch of fenofibrate capsules, USP in 43-mg and 130-mg strengths. The drug is the generic version of Antara (fenofibrate) capsules.

The Antara capsules brand and generics had U.S. sales of approximately $74 million MAT for the most recent 12 months ending February 2014, according to IMS Health. Dr. Reddy's fenofibrate capsules, USP 43-mg is available in bottle counts of 30; 130-mg are available in bottle counts of 30 and 90.